SEC Filing Alert
Peregrine Pharmaceuticals, Inc. has filed the following document(s) with the United States Securities and Exchange Commission.
________________________________________
Jul 11, 2012
Form SC 13G/A / Amended Statement of Beneficial Ownership
HTML PDF
View all SEC Filings
You are subscribed to Peregrine Pharmaceuticals, Inc. Investor Relations'' e-mail alerts as ACIFUENG@CAJAMADRID.ES.
To update your e-mail and alert preferences, please click here.
To unsubscribe, please click here.
Peregrine Pharmaceuticals, Inc.
14282 Franklin Avenue , Tustin, CA 92780-7017
Service provided by Shareholder.com
Market Data 
Markets 
AI
